FAQs

An overview of cytokines and chemokines for researchers. Covers major families (interleukins, TNF superfamily, interferons, chemokines, growth factors), their roles in immune signaling, and the research tools used to study them including recombinant proteins, antibodies, and ELISA kits.

A practical guide to blocking and permeabilization for immunoassays. Covers blocking agents (BSA, normal serum, casein, commercial blockers), permeabilization methods (Triton X-100, saponin, methanol, digitonin), application-specific recommendations, and troubleshooting non-specific background.

An introduction to surface plasmon resonance (SPR) and biolayer interferometry (BLI) for measuring antibody binding kinetics. Covers how each technology works, key parameters (KD, kon, koff), experimental design, and when to use SPR vs. BLI in antibody development and quality control.

An overview of stable cell line development for recombinant protein and antibody production. Covers the workflow from gene construct design through transfection, selection, single-cell cloning, and scale-up, with practical tips on host cell selection, expression vector design, and screening strategies.

A comprehensive hub page for oncology research reagents. Covers immune checkpoint antibodies, ADC targets, tumor microenvironment markers, cancer signaling pathway proteins, and research biosimilar reference antibodies across 20+ cancer types.

Complete guide to immune checkpoint targets for cancer research. Covers PD-1/PD-L1, CTLA-4, LAG-3, TIGIT, TIM-3, CD47, B7-H3 — mechanisms, approved therapies, and 1,170+ research reagents including antibodies, proteins, and biosimilars at abinScience.

Overview of key ADC drug targets with research reagents. Covers HER2, TROP2, Claudin 18.2, Nectin-4, CD33, BCMA, Mesothelin, and Tissue Factor — with target biology, approved ADCs, and available antibodies, proteins, and biosimilars.

Overview of the tumor microenvironment for researchers. Covers immune cell populations (TILs, TAMs, MDSCs, Tregs, DCs), stromal components (CAFs, endothelial cells), key signaling pathways (TGF-beta, CXCR4, CSF1R), and reagents for TME profiling by flow cytometry, IHC, and multiplex IF.

Research reagents for PD-1 and PD-L1 studies. Covers target biology, checkpoint blockade mechanism, available antibody clones (detection and neutralizing), recombinant proteins, and biosimilar reference antibodies for PK/ADA assays.

Research reagents for CTLA-4 (CD152) studies. Covers target biology, role in T cell priming, approved drugs, and available antibodies, proteins, and biosimilars.